Journal of Clinical Lipidology
Volume 4, Issue 5 , Pages 420-426, September 2010

Complete Apo AI Deficiency in an Iraqi Mandaean Family: Case studies and review of the literature

  • Ahmad Al-Sarraf, MD

      Affiliations

    • Healthy Heart Program Prevention Clinic, St. Paul's Hospital, 1081 Burrard Street, Vancouver, British Columbia, Canada, BC V6Z 1Y6
    • Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
    • Both authors contributed as first author.
  • ,
  • Khalid Al-Ghofaili, MD, FRCP(C)

      Affiliations

    • Healthy Heart Program Prevention Clinic, St. Paul's Hospital, 1081 Burrard Street, Vancouver, British Columbia, Canada, BC V6Z 1Y6
    • Both authors contributed as first author.
  • ,
  • David R. Sullivan, MBBS, FRACP, FRCPA

      Affiliations

    • Department of Clinical Biochemistry, Royal Prince Alfred Hospital, New South Wales, Australia
  • ,
  • Kishor M. Wasan, RPh, PhD

      Affiliations

    • Faculty of Pharmaceutical Sciences, UBC, Vancouver, BC, Canada
  • ,
  • Robert Hegele, MD, FRCP(C), FACP

      Affiliations

    • Roberts Research Institute, London, Ontario, Canada
  • ,
  • Jiri Frohlich, MD, FRCP(C)

      Affiliations

    • Healthy Heart Program Prevention Clinic, St. Paul's Hospital, 1081 Burrard Street, Vancouver, British Columbia, Canada, BC V6Z 1Y6
    • Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
    • Corresponding Author InformationCorresponding author.

Received 22 March 2010; accepted 17 May 2010. published online 31 May 2010.

Abstract

Complete apo A1 deficiency is a rare genetic disorder that has been associated with premature atherosclerosis. We describe a family of Iraqi Mandaean background with complete apo A1 deficiency caused by a new nonsense mutation in the APOA1 gene. Interestingly, there were marked differences in the clinical presentation of the two homozygotes in this family. A 35-year-old woman presented with xanthelasmas and xanthomas but showed only minimal changes on cardiovascular examinations and no clinical symptoms. However, her 37-year-old brother was diagnosed with myocardial infarction at age 35. In addition, both the homozygotes had elevated C-reactive protein levels. The C-reactive protein levels increased three-fold during pregnancy, then decreased postpartum and further decreased with statin treatment. Cholesterol ester transfer protein mass was close to the upper reference range, whereas the activity was low, likely because of the lack of the substrate. Here, we characterize the phenotype and genotype of the first Middle Eastern family with apo A1 deficiency and compare and contrast the findings in the two homozygous siblings and review the previously reported cases of apo A1 deficiency.

Keywords: Apo A-1, Cholesterol efflux, CRP, Electrophoresis, Nonsense mutation, Oxidized LDL

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1933-2874(10)00223-0

doi:10.1016/j.jacl.2010.05.001

Journal of Clinical Lipidology
Volume 4, Issue 5 , Pages 420-426, September 2010